1. CMU Intellectual Repository

Browsing by Author Tawesak Tanwandee

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)
1-Mar-2022Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai populationSakkarin Chirapongsathorn; Tongluk Teerasarntipan; Krit Tipchaichatta; Tanita Suttichaimongkol; Naichaya Chamroonkul; Chalermrat Bunchorntavakul; Sith Siramolpiwat; Siwaporn Chainuvati; Abhasnee Sobhonslidsuk; Apinya Leerapun; Teerha Piratvisuth; Wattana Sukeepaisarnjaroen; Tawesak Tanwandee; Sombat Treeprasertsuk
1-Jun-2012Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label studyChristophe Moreno; Thomas Berg; Tawesak Tanwandee; Satawat Thongsawat; Hans Van Vlierberghe; Stefan Zeuzem; Oliver Lenz; Monika Peeters; Vanitha Sekar; Goedele De Smedt
1-Jan-2018Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: A multicentre studyKessarin Thanapirom; Sirinporn Suksawatamnuay; Wattana Sukeepaisarnjaroen; Sombat Treeprasertsuk; Tawesak Tanwandee; Phunchai Charatcharoenwitthaya; Satawat Thongsawat; Apinya Leerapun; Teerha Piratvisuth; Rattana Boonsirichan; Chalermrat Bunchorntavakul; Chaowalit Pattanasirigool; Bubpha Pornthisarn; Supoj Tuntipanichteerakul; Ekawee Sripariwuth; Woramon Jeamsripong; Theeranun Sanpajit; Yong Poovorawan; Piyawat Komolmit
1-Oct-2021Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis BEdward Gane; Man Fung Yuen; Dong Joon Kim; Henry Lik Yuen Chan; Bernadette Surujbally; Vedran Pavlovic; Sudip Das; Miriam Triyatni; Remi Kazma; Joseph F. Grippo; Simon Buatois; Annabelle Lemenuel-Diot; Ben Fillippo Krippendorff; Henrik Mueller; Yuchen Zhang; Hyung Joon Kim; Apinya Leerapun; Tien Huey Lim; Young Suk Lim; Tawesak Tanwandee; Won Kim; Wendy Cheng; Tsung Hui Hu; Cynthia Wat
7-Aug-2022Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinomaJuliane Malik; Martin Klammer; Vinzent Rolny; Henry Lik Yuen Chan; Teerha Piratvisuth; Tawesak Tanwandee; Satawat Thongsawat; Wattana Sukeepaisarnjaroen; Juan Ignacio Esteban; Marta Bes; Bruno Köhler; Magdalena Swiatek-De Lange
1-Jan-2022Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in ThailandPiyameth Dilokthornsakul; Ratree Sawangjit; Pisit Tangkijvanich; Maneerat Chayanupatkul; Tawesak Tanwandee; Wattana Sukeepaisarnjaroen; Pajaree Sriuttha; Unchalee Permsuwan
1-Mar-2017Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter studyKessarin Thanapirom; Sirinporn Suksawatamnuay; Wattana Sukeepaisarnjareon; Tawesak Tanwandee; Phunchai Charatcharoenwitthaya; Satawat Thongsawat; Apinya Leerapun; Teerha Piratvisuth; Rattana Boonsirichan; Chalermrat Bunchorntavakul; Chaowalit Pattanasirigool; Bubpha Pornthisarn; Supot Tantipanichtheerakul; Ekawee Sripariwuth; Woramon Jeamsripong; Teeranan Sanpajit; Yong Poovorawan; Piyawat Komolmit
1-Jan-2011Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patientsKeyur Patel; Alexander J. Thompson; Wan Long Chuang; Chuan Mo Lee; Chen Yuan Peng; Ganesananthan Shanmuganathan; Satawat Thongsawat; Tawesak Tanwandee; Varocha Mahachai; Chutima Pramoolsinsap; Mong Cho; Kwang Hyup Han; Samir R. Shah; Graham R. Foster; Paul J. Clark; Erik Pulkstenis; G. Mani Subramanian; John G. Mchutchison
1-Apr-2022Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control StudyTeerha Piratvisuth; Tawesak Tanwandee; Satawat Thongsawat; Wattana Sukeepaisarnjaroen; Juan Ignacio Esteban; Marta Bes; Bruno Köhler; Ying He; Magdalena Swiatek-de Lange; David Morgenstern; Henry Lik Yuen Chan
1-May-2014Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burdenSatawat Thongsawat; Teerha Piratvisuth; Chutima Pramoolsinsap; Anuchit Chutaputti; Tawesak Tanwandee; Dittaya Thongsuk
1-Nov-2006Risk factors of hepatitis C virus infection in blood donors in Thailand: A multicenter case-control studyTawesak Tanwandee; Teerha Piratvisuth; Kannilka Phornphutkul; Pisaln Mairiang; Parichart Permpikul; Yong Poovorawan
1-Oct-2016Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosisJia Horng Kao; Shui Yi Tung; Younjae Lee; Satawat Thongsawat; Tawesak Tanwandee; I. Shyan Sheen; Jinzi J. Wu; Hui Li; Barbara J. Brennan; Julian Zhou; Sophie Le Pogam; Isabel Najera; James A. Thommes; George Hill
1-Nov-2016Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort studyPhunchai Charatcharoenwitthaya; Wattana Sukeepaisarnjaroen; Teerha Piratvisuth; Satawat Thongsawat; Theeranun Sanpajit; Soonthorn Chonprasertsuk; Woramon Jeamsripong; Ekawee Sripariwuth; Piyawat Komolmit; Tanisa Patcharatrakul; Rattana Boonsirichan; Chalermrat Bunchorntavakul; Supoj Tuntipanichteerakul; Tawesak Tanwandee
1-Jan-2019Vitamin D-binding protein gene polymorphism predicts pegylated interferon-related HBsAg seroclearance in HBeAg-negative Thai chronic hepatitis B patients: A multicentre studyKessarin Thanapirom; Sirinporn Suksawatamnuay; Wattana Sukeepaisarnjaroen; Sombat Treeprasertsuk; Tawesak Tanwandee; Phunchai Charatcharoenwitthaya; Satawat Thongsawat; Apinya Leerapun; Teerha Piratvisuth; Rattana Boonsirichan; Chalermrat Bunchorntavakul; Chaowalit Pattanasirigool; Bubpha Pornthisarn; Supot Tuntipanichteerakul; Ekawee Sripariwuth; Woramon Jeamsripong; Theeranan Sanpajit; Yong Poovorawan; Piyawat Komolmit
Showing results 1 to 14 of 14